Division of Pediatric Gastroenterology, Hepatology and Nutrition, Children's Memorial Hospital, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
J Pediatr. 2013 Mar;162(3):505-9. doi: 10.1016/j.jpeds.2012.08.032. Epub 2012 Oct 9.
To assess whether patients with celiac disease (CD) are more likely than controls to develop abdominal pain (AP) and AP-associated functional gastrointestinal disorders (FGID) in long-term follow-up.
In a retrospective study, data on children (3-22 years old) with CD diagnosed between 2000 and 2010 were obtained. Parents were contacted by telephone at least 6 months after the diagnosis of CD and invited to participate in the study. Consenting parents completed: (1) a telephone questionnaire on the presence of gastrointestinal symptoms; and (2) the parent report version of the Questionnaire on Pediatric Gastrointestinal Symptoms-Rome III for cases and selected controls.
Forty-nine cases (mean 11.3 years, 20 male participants) and 48 controls (mean 11.1 years, 24 male participants) were enrolled. Twelve children in the CD group (24.5%) and 7 children in the control group (14.6%) had AP at the time of the study (P = .3). Nine children in the CD group (18.3%) and 4 children in the control group (8.3%) met criteria for an AP-associated FGID according to the Questionnaire on Pediatric Gastrointestinal Symptoms-Rome III (P = .23).
It was found that children with CD and controls have a similar risk of AP and AP-FGIDs. Methodologic limitations prevent generalization of results, but large prospective studies should confirm the findings.
评估乳糜泻(CD)患者在长期随访中发生腹痛(AP)和与 AP 相关的功能性胃肠疾病(FGID)的可能性是否高于对照组。
在一项回顾性研究中,获取了 2000 年至 2010 年间诊断为 CD 的儿童(3-22 岁)的数据。通过电话联系父母,在 CD 诊断后至少 6 个月邀请他们参加研究。同意参加的父母完成了以下两项内容:(1)通过电话询问胃肠道症状的存在;(2)对病例和部分对照组使用儿科胃肠道症状罗马 III 问卷的父母报告版本。
纳入了 49 例病例(平均年龄 11.3 岁,20 名男性参与者)和 48 名对照组(平均年龄 11.1 岁,24 名男性参与者)。在研究时,CD 组中有 12 名儿童(24.5%)和对照组中有 7 名儿童(14.6%)有 AP(P=0.3)。根据儿科胃肠道症状罗马 III 问卷,CD 组中有 9 名儿童(18.3%)和对照组中有 4 名儿童(8.3%)符合与 AP 相关的 FGID 标准(P=0.23)。
发现 CD 儿童和对照组发生 AP 和 AP-FGID 的风险相似。方法学限制限制了结果的推广,但应进行大型前瞻性研究来证实这些发现。